Density of microvessels positive for CD105 (endoglin) is related to prognosis in meningiomas

Acta Neuropathologica

Volumn 114, Issue 2, 2007, Pages 147-156

  Barresi, Valeria ^a,c   Cerasoli, Serenella ^b   Vitarelli, Enrica ^a   Tuccari, Giovanni ^a  

^a UNIVERSITY OF MESSINA   (Italy)

^b BUFALINI HOSPITAL   (Italy)

^c UNIVERSITY OF MESSINA   (Italy)

Author keywords

CD105; CD34; Endoglin; Meningioma; Survival

Indexed keywords

BLOOD CLOTTING FACTOR 8; CD31 ANTIGEN; CD34 ANTIGEN; ENDOGLIN; FORMALDEHYDE; KI 67 ANTIGEN; PARAFFIN;

ADULT; AGE; AGED; ANGIOGENESIS; ANTIGEN EXPRESSION; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DENSITY; DISEASE FREE SURVIVAL; DRUG TARGETING; EMBEDDING; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LEPTOMENINX; MAJOR CLINICAL STUDY; MALE; MENINGIOMA; MICROVASCULATURE; NEUROSURGERY; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; QUANTITATIVE ANALYSIS; SEX DIFFERENCE; TUMOR BLOOD FLOW; TUMOR LOCALIZATION;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD; ANTIGENS, CD34; CAPILLARIES; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIERS ESTIMATE; MALE; MENINGEAL NEOPLASMS; MENINGIOMA; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; PROGNOSIS; RECEPTORS, CELL SURFACE; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL;

EID: 34547124346     PISSN: 00016322     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00401-007-0251-4     Document Type: Article

References (45)

1. Adam PJ, Clesham GJ, Weissberg PL (1998) Expression of endoglin m-RNA and protein in human vascular smooth muscle cells. Biochem Byophis Res Commun 247:33-37
2. Assimakopoulou M, Sotiropoulou-Bonikou G, Maraziotis T, Papadakis N, Varakis I (1997) Microvessel density in brain tumors. Anticancer Res 17:4747-4753
3. Barresi V, Cerasoli S, Paioli G, Vitarelli E, Giuffrè G, Tuccari G, Barresi G (2006) Caveolin-1 in meningiomas: Expression and clinico-pathological correlations. Acta Neuropathol 112:617-626
4. Behrem S, Zrkovic K, Eskina N, Jonjic N (2005) Endoglin is a better marker than CD31 in evaluation of angiogenesis in glioblastoma. Croat Med J 46:417-422
5. Bodey B, Bodey B Jr, Siegel SE, Kaiser HE (1998) Upregulation of endoglin (CD105) expression during childhood brain tumor-related angiogenesis. Anti-angiogenic therapy. Anticancer Res 18:1485-1500
6. Burrows FJ, Derbyshire EJ, Tazzari PL, Amlot P, Gazdar AF, King SW, Letarte M, Vitetta ES, Thorpe PE (1995) Up-regulation of endoglin on vascular endothelial cells in human solid tumours: Implications for diagnosis and therapy. Clin Cancer Res 1:1623-1634
7. Cheifetz S, Bellon T, Cales C, Vera S, Bernabeu C, Massague J, Letarte M (1992) Endoglin is a component of the transforming growth factor-beta receptor system in human endothelial cells. J Biol Chem 267:19027-19030
8. Christov C, Lechapt-Zalcman E, Adle-Biassette H, Nachev S, Gherardi RK (1999) Vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) and its receptor flt-1 in microcystic meningiomas. Acta Neuropathol 98:414-420
9. Dallago CM, Oliveira MC, Barbosa-Coutinho LM, Ferreira NP (2005) Angiogenesis in craniopharyngiomas: Microvascular density and tissue expression of the vascular endothelial growth factor (VEGF) and endostatin. Endocr Pathol 16:355-362
10. Ding S, Li C, Lin S, Yang Y, Liu D, Han Y, Zhang Y, Li L, Zhou L, Kumar S (2006) Comparative evaluation of microvessel density determined by CD34 or CD105 in benign and malignant gastric lesions. Hum Pathol 37:861-866
11. Folkman J (1990) What is the evidence that tumour are angiogenesis dependent? J Natl Cancer Inst 82:4-6
12. Folkman J, Shing Y (1992) Angiogenesis. J Biol Chem 267:10931-10934
13. Folkman J (1995) Clinical applications of angiogenesis research. N Engl J Med 333:1757-1763
14. Gougos A, St Jacques S, Greaves A, O'Connell PJ, d'Apice AJ, Buhring HJ, Bernabeu C, van Mourik JA, Letarte M (1992) Identification of distinct epitopes of endoglin, an RGD-containing glycoprotein of endothelial cells, leukemic cells, and syncytiotrophoblasts. Int Immunol 4:83-92
15. Hanahan D, Folkman J (1996) Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86:353-364
16. Hlatky L, Hahnfeldt P, Folkman J (2002) Clinical application of antiangiogenic therapy: Microvessel density, what it does and does not tell us. J Natl Cancer Inst 94:883-893
17. Kleihues P, Cavenee WK (eds) (2000) Pathology and genetics of tumours of the nervous system. IARC Press, Lyon
18. Kyzas PA, Agnantis NJ, Stefanou D (2006) Endoglin (CD105) as a prognostic factor in head and neck squamous cell carcinoma. Virchows Arch 448:768-775
19. Lamszus K, Lengler U, Schmidt NO, Stavrou D, Ergun S, Westphal M (2000) Vascular endothelial growth factor, hepatocyte growth factor/scatter factor, basic fibroblast growth factor, and placenta growth factor in human meningiomas and their relation to angiogenesis and malignancy. Neurosurgery 46:938-947
20. Lewy-Trenda I, Omulecka A, Janczukowicz J, Papierz W (2003) The morphological analysis of vasculature and angiogenic potential in meningiomas: Immunoexpression of CD31 and VEGF antibodies. Folia Neuropathol 41:149-153
21. Maiuri F, De Caro Mdel B, Esposito F, Cappabianca P, Strazzullo V, Pettinato G, de Divitiis E (2007) Recurrences of meningiomas: Predictive value of pathological features and hormonal and growth factors. J Neurooncol 82:63-68
22. Maxwell PH, Dachs GU, Gleade JM, Nicholls LG, Harris AL, Stratford IJ, Hankinson O, Pugh CW, Ratcliffe PJ (1997) Hypoxia-inducible factor-1 modulates gene expression in solid tumors and influences both angiogenesis and tumor growth. Proc Natl Acad Sci USA 94: 8104-8109
23. Miller DW, Graulich W, Karges B, Stahl S, Ernst M, Ramaswamy A, Sedlacek HH, Muller R, Adamkiewicz J (1999) Elevated expression of endoglin, a component of the TGF-β receptor complex, correlates with proliferation of tumour endothelial cells. Int J Cancer 81:568-572
24. Minhajat R, Mori D, Yamasaki F, Sugita Y, Satoh T, Tokunaga O (2006) Endoglin (CD105) expression in angiogenesis of colon cancer: Analysis using tissue microarrays and comparison with other endothelial markers. Virchows Arch 448:127-134
25. Nishio S, Takeshita I, Morioka T, Fukui M (1994) Microcystic meningiomas: Climicopathological features of 6 cases. Neurol Res 16:251-256
26. Perry A, Stafford SL, Scheithauer BW, Suman VJ, Lohse CM (1998) The prognostic significance of MIB-1, p53, and DNA flow cytometry in completely resected primary meningiomas. Cancer 82:2262-2269
27. Perry A, Stafford SL, Scheithauer BW, Lohse CM, Wollan PC (1999) "Malignancy" in meningiomas: A clinico-pathological study of 116 patients with grading implications. Cancer 85:2046-2056
28. Pistolesi S, Boldrini L, Gisfredi S, De Ieso K, Camacci T, Caniglia M, Lupi G, Leocata P, Basolo F, Pingitore R, Parenti G, Fontanini G (2004) Angiogenesis in intracranial meningiomas: Immunohistochemical and molecular study. Neuropathol Appl Neurobiol 30:118-25
29. Provias J, Claffey K, delAguila L, Lau N, Feldkamp M, Guha A (1997) Meningiomas: Role of vascular endothelial growth factor/vascular permeability factor in angiogenesis and peritumoral edema. Neurosurgery 40:1016-1026
30. Romani AA, Borghetti AF, Del Rio P, Sianesi M, Soliani P (2006) The risk of developing metastatic disease in colorectal cancer is related to CD105-positive vessel count. J Surg Oncol 93:446-455
31. Saad RS, El-Gohary Y, Memari E, Liu YL, Silverman JF (2005) Endoglin (CD105) and vascular endothelial growth factor as prognostic markers in esophageal adenocarcinoma. Hum Pathol 36:955-961
32. Saad RS, Jasnosz KM, Silverman JF (2003) Endoglin (CD105) expression in endometrial carcinoma. Int J Gynecol Pathol 22:248-253
33. Sanchez-Elsner T, Botella LM, Velasco B, Langa C, Bernabeu C (2002) Endoglin expression is up-regualted by transcriptional cooperation between the hypoxia and the transforming-growth factor-beta pathways. J Biol Chem 277:43799-43808
34. Sandlund J, Hedberg Y, Bergh A, Grankvist K, Ljunberg B, Rasmuson T (2006) Endoglin (CD105) expression in human renal cell carcinoma. BJU Int 97:706-710
35. Shono T, Inamura T, Torisu M, Suzuki SO, Fukui M (2000) Vascular endothelial growth factor and malignant transformation of a meningioma: a case report. Neurol Res 22:189-193
36. Simpson D (1957) The recurrence of intracranial meningiomas after surgical treatment. J Neurol Neurosurg Psychiatry 20:22-39
37. Sugita Y, Takase Y, Mori D, Tokunaga O, Nakashima A, Shigemori M (2006) Endoglin (CD 105) is expressed on endothelial cells in the primary central nervous system lymphomas and correlates with survival. J Neurooncol (Epub ahead of print)
38. Torsney E, Charlton R, Parums D, Collis D, Arthur HM (2002) Inducible expression of human endoglin during inflammation and wound healing in vivo. Inflamm Res 51:464-470
39. Wang JM, Kumar S, Pye D, van Aghtoven AJ, Krupinski J, Hunter RD (1993) A monoclonal antibody detects heterogeneity in vacular endothelium of tumours and normal tissues. Int J Cancer 54:363-370
40. Wang JM, Kumar S, Pye D, Haboubi N, Al-Nakib L (1994) Breast carcinoma: a comparative study of tumour vasculature using two endothelial cell markers. J Natl Cancer Inst 86:386-388
41. Weidner N, Semple JP, Welch WR, Folkman J (1991) Tumor angiogenesis and metastasis - correlation in invasive breast carcinoma. N Engl J Med 324:1-8
42. Weir EE, Pretlow TG, Pitts A (1974) A more sensitive and specific histochemical peroxidase stain for the localization of cellular antigen by the enzyme-antibody conjugated method. J Histochem Cytochem 22:1135-1140
43. Yao Y, Kubota T, Takeuchi H, Sato K (2005) Prognostic significance of microvessel density determined by an anti-CD105/endoglin monoclonal antibody in astrocytic tumors: Comparison with an anti-CD31 monoclonal antibody. Neuropathology 25:201-206
44. Yoo H, Baia GS, Smith JS, McDermott MW, Bollen AW, Vandenberg SR, Lamborn KR, Lal A (2007) Expression of hypoxia marker carbonic anhydrase 9 is associated with anaplastic phenotypes in meningiomas. Clin Cancer Res 13:68-75
45. Zhu Y, Sun Y, Xie L, Jin K, Sheibani N, Greenberg DA (2003) Hypoxic induction of endoglin via mitogen-activated protein kinases in mouse brain microvascular endothelial cells. Stroke 34:2483-2488